Risks of intravitreous injection: a comprehensive review.
about
Corticosteroid implants for chronic non-infectious uveitisCorticosteroid implants for chronic non-infectious uveitisAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degenerationDexamethasone intravitreal implant in the treatment of diabetic macular edemaEmerging biological therapies for age-related macula degeneration.Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis)Episcleral clearance of sodium fluorescein from a bioerodible sub-tenon's implant in the rat.Experimental investigation of needles, syringes and techniques for intravitreal injections.Early clinical characteristics of bacterial endophthalmitis in retinopathy of prematurity after intravitreal bevacizumab injection: A case report.Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectivesIntrascleral drug delivery to the eye using hollow microneedles.Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eyeOcular delivery of macromoleculesRecurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab.Tower microneedle via reverse drawing lithography for innocuous intravitreal drug delivery.Diabetic Retinopathy-Update on Prevention Techniques, Present Therapies, and New Leads.Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases.Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications.Ocular pharmacokinetics of fluocinolone acetonide following Iluvien implantation in the vitreous humor of rabbitsOcular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degenerationThe distribution of Mn2+ in rabbit eyes after topical administration for manganese-enhanced MRI.One-Year Feasibility Study of Replenish MicroPump for Intravitreal Drug Delivery: A Pilot Study.Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT)The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.The effects of injection site on the reflux following intravitreal injections.Phacoemulsification and intraocular lens implantation after inadvertent intracapsular injection of intravitreal dexamethasone implantMultivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.Sustained release micellar carrier systems for iontophoretic transport of dexamethasone across human sclera.A microparticle/hydrogel combination drug-delivery system for sustained release of retinoids.Topical azithromycin or ofloxacin for endophthalmitis prophylaxis after intravitreal injectionThe pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.Complications of intravitreal triamcinolone acetonide for macular edema and predictive factors for intraocular pressure elevationTherapeutic potential of intravitreal pharmacotherapy in retinal vein occlusionPegaptanib: a novel approach to ocular neovascularization.Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi ArabiaLongitudinal Changes in Retinal Nerve Fiber Layer Thickness after Intravitreal Anti-vascular Endothelial Growth Factor Therapy.Slow-release drug delivery through Elvax 40W to the rat retina: implications for the treatment of chronic conditions.
P2860
Q24186144-89B795C7-A269-431F-9C0F-6A20D03BC608Q24198202-4B94B7EF-D8B1-4C4B-B75D-61D34431687CQ24243234-F844D6E3-54DB-4D74-A28F-278E46F7BC2CQ26799423-CC9765C0-F324-46FB-ACDF-F1C4AF55647DQ33224360-82D9A790-DFAB-4ECC-96CD-D08FA7674A21Q33397385-DE076942-401D-4E53-8188-27C8F8CCD32EQ33416826-6149ADFC-FF1E-4A30-9771-31F4A8C4EB30Q33523210-9B9EB6F8-D29F-40E1-B456-35C5E89EB098Q33727213-E7E680C5-6677-413E-997A-B0702826B8B7Q33745089-39A9F0DD-1AED-431C-89B6-F64DDC060129Q33774225-DF1C7823-A8AB-488F-9FCD-E8D5B94440C8Q33978350-DB506BB1-F33B-405F-BC38-3BCA948146E1Q34052958-AD7E41F5-D1FA-4DF7-A4B3-61FA2CDC70B0Q34079676-E7BDD862-188F-4F4F-85BE-FCCC385A7D02Q34106112-623044A7-92E5-4194-A020-A62DCFD126DEQ34499190-771D998E-ECCE-4848-A0D7-10D339397AA2Q34553087-688FD4B4-5DE2-43F8-A0C0-2FD2235B8B1EQ34658699-3459FA2A-03E7-4588-B317-7484657651E6Q34701929-627E08BA-14EA-432A-8680-76F02DD08C4BQ34862740-B1A7975E-3777-416B-94A2-D35DD738315EQ35127099-C2C5E9C4-EC1D-4810-B674-CCE45ABE00D4Q35145146-A33FC28B-8258-4B24-9A2B-DFFA5279CD7CQ35167647-E261ABE0-A952-487C-AC77-EEE8925AB945Q35693314-B826442F-A578-4084-8EA6-858FC8DE65A4Q35706804-830AC37C-EAAE-4618-9118-45777C4A45CCQ35742777-3450B015-D42A-457E-A3DC-22A2FAF0276AQ35762657-D44C0881-88C6-4352-BF23-F53BC75C144BQ35850012-7A8D4247-66DC-4E90-BA2C-1177CFB0B1B7Q35980294-A533E098-EC75-4734-BE65-CE7F066F64CAQ35991894-7C5D91CD-52AB-4ECF-A081-AE4F0FFA80AFQ36024067-4505E12A-BCC6-4830-A0BB-913CE9BBA49FQ36299877-AF90702D-56D4-4D61-BC9C-8200B8239008Q36326803-CEB83233-E0A7-47E5-9195-460A5C5B1942Q36441711-9A06E09C-09DC-4F8A-96A1-AC8AB3691F03Q36490459-9F292C20-B896-404F-B174-4F1DB3C44ACCQ36490483-D4BE6B43-EC5C-4296-B0C3-82543773DE3DQ36540129-FF9CC332-2C3C-4EA2-AC02-07A4BA2B4BA9Q36596476-3458CA05-D98E-4D48-95F0-45D94D6BFA25Q36764415-803BDB9B-1CBC-48DB-9E67-69B2009A62D2Q36788228-AF586EE9-0427-4BDB-BD73-3A7178B0C7AF
P2860
Risks of intravitreous injection: a comprehensive review.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Risks of intravitreous injection: a comprehensive review.
@ast
Risks of intravitreous injection: a comprehensive review.
@en
type
label
Risks of intravitreous injection: a comprehensive review.
@ast
Risks of intravitreous injection: a comprehensive review.
@en
prefLabel
Risks of intravitreous injection: a comprehensive review.
@ast
Risks of intravitreous injection: a comprehensive review.
@en
P2093
P1433
P1476
Risks of intravitreous injection: a comprehensive review.
@en
P2093
Emmett T Cunningham
Lloyd Paul Aiello
Rama D Jager
Samir C Patel
P304
P356
10.1097/00006982-200410000-00002
P577
2004-10-01T00:00:00Z